✦ LIBER ✦

Monitoring psoriasis patients being treated with tumour necrosis factor inhibitors: use your judgment

✍ Scribed by S.R. Feldman

Book ID: 108671818
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 47 KB
Volume: 165
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2011.10422.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical experience of QuantiFERON®-TB G

Clinical experience of QuantiFERON®-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan

✍ H-Y. Chiu; P-R. Hsueh; T-F. Tsai 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Using ‘number needed to treat’ to help c

Using ‘number needed to treat’ to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-α inhibitors for patients with severe psoriasis

✍ J.W. Dharamsi; M. Bhosle; R. Balkrishnan; B.A. Yentzer; S.R. Feldman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE

✍ J.-P. Ortonne; S. Chimenti; K. Reich; R. Gniadecki; P. Sprøgel; K. Unnebrink; H. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

Individualized monitoring of drug bioava

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab

✍ Klaus Bendtzen; Pierre Geborek; Morten Svenson; Lotta Larsson; Meliha C. Kapetan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## Objective Infliximab, an anti–tumor necrosis factor α (anti‐TNFα) antibody, is effective in the treatment of several immunoinflammatory diseases. However, many patients experience primary or secondary response failure, suggesting that individualization of treatment regimens may be b

Tumour necrosis factor α (TNF-α)-convert

Tumour necrosis factor α (TNF-α)-converting enzyme (TACE) and soluble TNF-α receptor type 1 in psoriasis patients treated with narrowband ultraviolet B

✍ Agnieszka Beata Serwin; Marianna Sokolowska; Bozena Chodynicka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Tuberculosis and tumour necrosis factor-

Tuberculosis and tumour necrosis factor-α inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians

✍ A. Perlmutter; A. Mittal; A. Menter 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB